• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两例携带p.Arg4810Lys变异体的伴有特定血管畸形和独特嗜酸性粒细胞炎症的肺动脉高压病例系列

Two cases of pulmonary arterial hypertension with specific vascular Мalformations and unique eosinophilic inflammation in carriers of the p. Arg4810Lys variant: Case series.

作者信息

Takeda Kenichiro, Sekine Ayumi, Tanabe Nobuhiro, Sugiura Toshihiko, Shigeta Ayako, Kitahara Shinsuke, Imai Shun, Okaya Tadasu, Nagata Jun, Naito Akira, Sakao Seiichiro, Tatsumi Koichiro, Suzuki Takuji

机构信息

Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.

Department of Respirology, Chibaken Saiseikai Narashino Hospital, Narashino, Japan.

出版信息

Respir Med Case Rep. 2023 Mar 4;42:101829. doi: 10.1016/j.rmcr.2023.101829. eCollection 2023.

DOI:10.1016/j.rmcr.2023.101829
PMID:36936868
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10015230/
Abstract

p.Arg4810Lys is linked to various vascular diseases, including pulmonary arterial hypertension (PAH); however, its pathogenesis remains unclear. Here, we report the unique features of two cases of severe PAH with this variant: one is the first reported case with stenosis of the thoracic and abdominal aorta, femoral arteries, and subclavian veins. Coexistence of severe and continuous eosinophilic inflammation, which has been suspected to be implicated in the pathogenesis of PAH in previous fundamental studies, was also present in both cases. Further studies are needed to clarify the pathogenetic mechanisms in vascular lesions with this variant.

摘要

p.Arg4810Lys与包括肺动脉高压(PAH)在内的多种血管疾病相关;然而,其发病机制仍不清楚。在此,我们报告了两例携带此变异的严重PAH病例的独特特征:一例是首例报告的伴有胸主动脉、腹主动脉、股动脉和锁骨下静脉狭窄的病例。两例病例均存在严重且持续的嗜酸性粒细胞炎症,在先前的基础研究中怀疑其与PAH的发病机制有关。需要进一步研究以阐明携带此变异的血管病变的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8196/10015230/1585ad49134d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8196/10015230/d310a0db1417/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8196/10015230/1585ad49134d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8196/10015230/d310a0db1417/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8196/10015230/1585ad49134d/gr2.jpg

相似文献

1
Two cases of pulmonary arterial hypertension with specific vascular Мalformations and unique eosinophilic inflammation in carriers of the p. Arg4810Lys variant: Case series.两例携带p.Arg4810Lys变异体的伴有特定血管畸形和独特嗜酸性粒细胞炎症的肺动脉高压病例系列
Respir Med Case Rep. 2023 Mar 4;42:101829. doi: 10.1016/j.rmcr.2023.101829. eCollection 2023.
2
Poor outcomes in carriers of the RNF213 variant (p.Arg4810Lys) with pulmonary arterial hypertension.携带 RNF213 变异(p.Arg4810Lys)的肺动脉高压患者预后不良。
J Heart Lung Transplant. 2020 Feb;39(2):103-112. doi: 10.1016/j.healun.2019.08.022. Epub 2019 Sep 2.
3
Nonsyndromic Peripheral Pulmonary Artery Stenosis Is Associated With Homozygosity of RNF213 p.Arg4810Lys Regardless of Co-occurrence of Moyamoya Disease.非综合征性周围性肺动脉狭窄与 RNF213 p.Arg4810Lys 纯合子相关,无论是否伴有烟雾病。
Chest. 2018 Feb;153(2):404-413. doi: 10.1016/j.chest.2017.09.023. Epub 2017 Sep 28.
4
Hemorrhagic Onset Intracranial Artery Dissection of Middle Cerebral Artery Followed by Progressive Arterial Stenosis with Genetic Variant RNF213 p.Arg4810Lys (rs112735431).大脑中动脉出血性起始颅内动脉夹层,随后出现进行性动脉狭窄,伴有 RNF213 p.Arg4810Lys(rs112735431)基因变异。
World Neurosurg. 2020 Sep;141:192-195. doi: 10.1016/j.wneu.2020.04.241. Epub 2020 May 11.
5
-Associated Vascular Disease: A Concept Unifying Various Vasculopathies.相关血管疾病:一个统一各种血管病变的概念。
Life (Basel). 2022 Apr 8;12(4):555. doi: 10.3390/life12040555.
6
Association between RNF213 c.14576G>A Variant (rs112735431) and Peripheral Pulmonary Artery Stenosis in Moyamoya Disease.RNF213基因c.14576G>A变异(rs112735431)与烟雾病外周肺动脉狭窄的关联。
Cerebrovasc Dis. 2022;51(3):282-287. doi: 10.1159/000519717. Epub 2021 Oct 28.
7
Ring Finger Protein 213 in Moyamoya Disease With Pulmonary Arterial Hypertension: A Mini-Review.伴肺动脉高压的烟雾病中的无名指蛋白213:一篇综述
Front Neurol. 2022 Mar 24;13:843927. doi: 10.3389/fneur.2022.843927. eCollection 2022.
8
Prospective Screening of Extracranial Systemic Arteriopathy in Young Adults with Moyamoya Disease.青年烟雾病患者颅外全身动脉系统前瞻性筛查。
J Am Heart Assoc. 2020 Oct 20;9(19):e016670. doi: 10.1161/JAHA.120.016670. Epub 2020 Sep 21.
9
[Genetic Factors of Intracranial Artery Stenosis and Potential for Personalized Medicine].[颅内动脉狭窄的遗传因素与个性化医疗潜力]
No Shinkei Geka. 2022 Jan;50(1):222-233. doi: 10.11477/mf.1436204547.
10
De Novo Development of Moyamoya Disease after Stereotactic Radiosurgery for Brain Arteriovenous Malformation in a Patient With RNF213 p.Arg4810Lys (rs112735431).RNF213 p.Arg4810Lys(rs112735431)突变患者接受脑动静脉畸形立体定向放射外科治疗后新发烟雾病
World Neurosurg. 2020 Aug;140:276-282. doi: 10.1016/j.wneu.2020.05.068. Epub 2020 May 17.

引用本文的文献

1
Multisystemic Impact of RNF213 Arg4810Lys: A Comprehensive Review of Moyamoya Disease and Associated Vasculopathies.RNF213基因Arg4810Lys位点的多系统影响:烟雾病及相关血管病变的综合综述
Int J Mol Sci. 2025 Aug 14;26(16):7864. doi: 10.3390/ijms26167864.

本文引用的文献

1
Eosinophils protect against pulmonary hypertension through 14-HDHA and 17-HDHA.嗜酸性粒细胞通过 14-HDHA 和 17-HDHA 来预防肺动脉高压。
Eur Respir J. 2023 Mar 2;61(3). doi: 10.1183/13993003.00582-2022. Print 2023 Mar.
2
-Associated Vascular Disease: A Concept Unifying Various Vasculopathies.相关血管疾病:一个统一各种血管病变的概念。
Life (Basel). 2022 Apr 8;12(4):555. doi: 10.3390/life12040555.
3
Idiopathic Hypereosinophilic Syndrome Associated With Pulmonary Hypertension in an Infant.婴儿特发性嗜酸性粒细胞增多综合征伴肺动脉高压。
J Pediatr Hematol Oncol. 2022 Jul 1;44(5):e881-e883. doi: 10.1097/MPH.0000000000002444. Epub 2022 Apr 1.
4
Severe thrombocytopenia in patients with idiopathic pulmonary arterial hypertension provided several strategies for lung transplantation.特发性肺动脉高压患者出现严重血小板减少为肺移植提供了多种策略。
Pulm Circ. 2020 Nov 20;10(4):2045894020969103. doi: 10.1177/2045894020969103. eCollection 2020 Oct-Dec.
5
Poor outcomes in carriers of the RNF213 variant (p.Arg4810Lys) with pulmonary arterial hypertension.携带 RNF213 变异(p.Arg4810Lys)的肺动脉高压患者预后不良。
J Heart Lung Transplant. 2020 Feb;39(2):103-112. doi: 10.1016/j.healun.2019.08.022. Epub 2019 Sep 2.
6
Genomic Comparison With Supercentenarians Identifies RNF213 as a Risk Gene for Pulmonary Arterial Hypertension.与超级百岁老人的基因组比较确定RNF213是肺动脉高压的风险基因。
Circ Genom Precis Med. 2018 Dec;11(12):e002317. doi: 10.1161/CIRCGEN.118.002317.
7
Genetics and genomics of pulmonary arterial hypertension.肺动脉高压的遗传学和基因组学。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01899-2018. Print 2019 Jan.
8
The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms.第 2 组先天淋巴细胞(ILC2)调节网络及其潜在机制。
Immunol Rev. 2018 Nov;286(1):37-52. doi: 10.1111/imr.12706.
9
Filarial tropical pulmonary eosinophilia: a condition masquerading asthma, a series of 12 cases.丝虫性热带肺嗜酸性粒细胞增多症:一种伪装成哮喘的病症,12例病例系列
J Asthma. 2019 Jul;56(7):791-798. doi: 10.1080/02770903.2018.1490748. Epub 2018 Aug 24.
10
IL-33 Initiates Vascular Remodelling in Hypoxic Pulmonary Hypertension by up-Regulating HIF-1α and VEGF Expression in Vascular Endothelial Cells.IL-33 通过上调血管内皮细胞中 HIF-1α 和 VEGF 的表达引发低氧性肺动脉高压中的血管重塑。
EBioMedicine. 2018 Jul;33:196-210. doi: 10.1016/j.ebiom.2018.06.003. Epub 2018 Jun 18.